HomeAI · summaries
Storia in 3 fonti
‘Paradigm-shifting’ treatment for pediatric diabetes cleared by FDA
Yale’s Kevan Herold was the senior investigator on a clinical trial which showed that the drug teplizumab — recently approved for pediatric patients with Stage 3 Type 1 diabetes — delays the progression of the disease.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
dailymail.com
Drug that delays type 1 diabetes by up to three years approved by NHS
The National Institute for Health and Care Excellence (Nice) has approved teplizumab, with Diabetes UK saying it 'marks the start of a new age of treatment'.
- ·
theguardian.com
Drug that delays onset of type 1 diabetes approved in England and Wales
Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an ‘incredible moment’
- ·
news.yale.edu
‘Paradigm-shifting’ treatment for pediatric diabetes cleared by FDA
Yale’s Kevan Herold was the senior investigator on a clinical trial which showed that the drug teplizumab — recently approved for pediatric patients with Stage 3 Type 1 diabetes —…